These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 25968593

  • 21. Comparison of the diagnostic and prognostic values of B-type and atrial-type natriuretic peptides in acute heart failure.
    Seronde MF, Gayat E, Logeart D, Lassus J, Laribi S, Boukef R, Sibellas F, Launay JM, Manivet P, Sadoune M, Nouira S, Solal AC, Mebazaa A, Great network.
    Int J Cardiol; 2013 Oct 09; 168(4):3404-11. PubMed ID: 23684562
    [Abstract] [Full Text] [Related]

  • 22. Influence of age, race, sex, and body mass index on interpretation of midregional pro atrial natriuretic peptide for the diagnosis of acute heart failure: results from the BACH multinational study.
    Daniels LB, Clopton P, Potocki M, Mueller C, McCord J, Richards M, Hartmann O, Anand IS, Wu AH, Nowak R, Peacock WF, Ponikowski P, Mockel M, Hogan C, Filippatos GS, Di Somma S, Ng L, Neath SX, Christenson R, Morgenthaler NG, Anker SD, Maisel AS.
    Eur J Heart Fail; 2012 Jan 09; 14(1):22-31. PubMed ID: 22140234
    [Abstract] [Full Text] [Related]

  • 23. Plasma midregional pro-atrial natriuretic peptide is associated with blood pressure indices and hypertension severity in adults with hypertension.
    Khaleghi M, Saleem U, Morgenthaler NG, Turner ST, Bergmann A, Struck J, Mosley TH, Kullo IJ.
    Am J Hypertens; 2009 Apr 09; 22(4):425-31. PubMed ID: 19214167
    [Abstract] [Full Text] [Related]

  • 24. Nt-proANP in plasma, a marker of salt sensitivity, is reduced in type 2 diabetes patients.
    Melander O, Frandsen E, Magnusson M, Grubb A, Jovinge S, Groop L.
    J Intern Med; 2005 Mar 09; 257(3):281-8. PubMed ID: 15715685
    [Abstract] [Full Text] [Related]

  • 25. Mid-regional pro atrial natriuretic peptide allows the accurate identification of patients with atrial fibrillation of short time of onset: a pilot study.
    Meune C, Vermillet A, Wahbi K, Guerin S, Aelion H, Weber S, Chenevier-Gobeaux C.
    Clin Biochem; 2011 Nov 09; 44(16):1315-9. PubMed ID: 21871875
    [Abstract] [Full Text] [Related]

  • 26. Midregional pro-A-type natriuretic peptide for diagnosis and prognosis in patients with suspected acute myocardial infarction.
    Meune C, Twerenbold R, Drexler B, Balmelli C, Wolf C, Haaf P, Reichlin T, Irfan A, Reiter M, Zellweger C, Meissner J, Stelzig C, Freese M, Capodarve I, Mueller C.
    Am J Cardiol; 2012 Apr 15; 109(8):1117-23. PubMed ID: 22257708
    [Abstract] [Full Text] [Related]

  • 27. Mid-regional pro-atrial natriuretic peptide levels in the elderly: clinical and prognostic implications, and comparison to B-type natriuretic peptides.
    Eggers KM, Venge P, Lind L.
    Clin Chim Acta; 2013 Apr 18; 419():62-6. PubMed ID: 23415698
    [Abstract] [Full Text] [Related]

  • 28. Midregional proatrial natriuretic peptide predicts survival in exacerbations of COPD.
    Bernasconi M, Tamm M, Bingisser R, Miedinger D, Leuppi J, Müller B, Christ-Crain M, Stolz D.
    Chest; 2011 Jul 18; 140(1):91-99. PubMed ID: 21106656
    [Abstract] [Full Text] [Related]

  • 29. MR-proANP and MR-proADM for risk stratification of patients with acute chest pain.
    Tzikas S, Keller T, Ojeda FM, Zeller T, Wild PS, Lubos E, Kunde J, Baldus S, Bickel C, Lackner KJ, Münzel TF, Blankenberg S.
    Heart; 2013 Mar 18; 99(6):388-95. PubMed ID: 23213173
    [Abstract] [Full Text] [Related]

  • 30. Mid-regional pro-atrial natriuretic peptide and copeptin as indicators of disease severity and therapy response in CTEPH.
    Kriechbaum SD, Scherwitz L, Wiedenroth CB, Rudolph F, Wolter JS, Haas M, Fischer-Rasokat U, Rolf A, Hamm CW, Mayer E, Guth S, Keller T, Konstantinides SV, Lankeit M, Liebetrau C.
    ERJ Open Res; 2020 Oct 18; 6(4):. PubMed ID: 33263045
    [Abstract] [Full Text] [Related]

  • 31. Respiratory morbidity in preterm infants predicted by natriuretic peptide (MR-proANP) and endothelin-1 (CT-proET-1).
    Gerull R, Neumann RP, Atkinson A, Bernasconi L, Schulzke SM, Wellmann S.
    Pediatr Res; 2022 May 18; 91(6):1478-1484. PubMed ID: 33958715
    [Abstract] [Full Text] [Related]

  • 32. Increased NT-proANP predicts risk of congestive heart failure in Cavalier King Charles spaniels with mitral regurgitation caused by myxomatous valve disease.
    Eriksson AS, Häggström J, Pedersen HD, Hansson K, Järvinen AK, Haukka J, Kvart C.
    J Vet Cardiol; 2014 Sep 18; 16(3):141-54. PubMed ID: 25130405
    [Abstract] [Full Text] [Related]

  • 33. Increased plasma levels of NT-proANP and NT-proBNP as markers of cardiac dysfunction in septic patients.
    Hoffmann U, Brueckmann M, Bertsch T, Wiessner M, Liebetrau C, Lang S, Haase KK, Borggrefe M, Huhle G.
    Clin Lab; 2005 Sep 18; 51(7-8):373-9. PubMed ID: 16122147
    [Abstract] [Full Text] [Related]

  • 34. Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death.
    Moertl D, Berger R, Struck J, Gleiss A, Hammer A, Morgenthaler NG, Bergmann A, Huelsmann M, Pacher R.
    J Am Coll Cardiol; 2009 May 12; 53(19):1783-90. PubMed ID: 19422985
    [Abstract] [Full Text] [Related]

  • 35. Effect of puberty on the relationship between circulating leptin and body composition.
    Horlick MB, Rosenbaum M, Nicolson M, Levine LS, Fedun B, Wang J, Pierson RN, Leibel RL.
    J Clin Endocrinol Metab; 2000 Jul 12; 85(7):2509-18. PubMed ID: 10902802
    [Abstract] [Full Text] [Related]

  • 36. Mid-regional pro-atrial natriuretic peptide levels before and after hemodialysis predict long-term prognosis.
    Hasselbalch RB, Kristensen JH, Nielsen TL, Plesner LL, Rydahl C, Schou M, Goetze JP, Bundgaard H, Iversen KK.
    Clin Biochem; 2021 Aug 12; 94():20-26. PubMed ID: 33865815
    [Abstract] [Full Text] [Related]

  • 37. The midregional fragment of pro-A-type natriuretic peptide, blood pressure, and mortality in a prospective cohort study of patients with type 2 diabetes (ZODIAC-25).
    van Hateren KJ, Landman GW, Kleefstra N, Groenier KH, Struck J, Navis GJ, Bakker SJ, Houweling ST, van der Meer K, Bilo HJ.
    Diabetes Care; 2013 May 12; 36(5):1347-52. PubMed ID: 23230100
    [Abstract] [Full Text] [Related]

  • 38. Midregional pro-atrial natriuretic peptide in the general population/Insights from the Gutenberg Health Study.
    Tzikas S, Keller T, Wild PS, Schulz A, Zwiener I, Zeller T, Schnabel RB, Sinning C, Lubos E, Kunde J, Münzel T, Lackner KJ, Blankenberg S.
    Clin Chem Lab Med; 2013 May 12; 51(5):1125-33. PubMed ID: 23183754
    [Abstract] [Full Text] [Related]

  • 39. Comparison of pleural N-terminal pro-B-type natriuretic peptide, midregion pro-atrial natriuretic peptide and mid-region pro-adrenomedullin for the diagnosis of pleural effusions associated with cardiac failure.
    Porcel JM, Bielsa S, Morales-Rull JL, Civit C, Cao G, Light RW, Esquerda A.
    Respirology; 2013 Apr 12; 18(3):540-5. PubMed ID: 23278975
    [Abstract] [Full Text] [Related]

  • 40. Plasma proatrial natriuretic peptide associates with lipid oxidation during exercise and cardiorespiratory fitness in healthy young adults.
    Thomsen CF, Ried-Larsen M, Goetze JP, Andersen LB, Faber J, Grøntved A, Jeppesen JL.
    Peptides; 2019 Dec 12; 122():170156. PubMed ID: 31550524
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.